Head and Neck Cancer: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner
Heidi Mason, DNP, ACNP-BC
J Adv Pract Oncol 2022;13(6):614-617 |
© 2022 Harborside™
Heidi Mason, DNP, ACNP-BC, of the University of Michigan School of Nursing, considers research on avoiding concurrent chemotherapy in patients with nasopharyngeal carcinoma being treated with radiotherapy and a clinical trial on concurrent vs. sequential fixed-dose immune therapy for head and neck cancer.
For access to the full length article, please sign in